Setmelanotide for treating acquired hypothalamic obesity in people 4 years and over ID6542 Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback